Product Number | Description | Price |
---|
00/410 | MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation) | £147.00 |
00/416 | Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation) | £147.00 |
00/418 | MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard) | £147.00 |
00/422 | High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation) | £147.00 |
00/440 | Influenza Antiserum A/Singapore/1/57 (H2) | £120.00 |
00/442 | Influenza anti B/Yamanashi/166/98 Serum | £120.00 |
00/498 | Diphtheria Antitoxin Human IgG | £132.00 |
00/500 | Botulinum Type A-E Antitoxin, Human Serum | £132.00 |
00/542 | Influenza anti- A/Chick/Scotland/59 (H5N1) Serum | £120.00 |
00/546 | Influenza Antigen B/Johannesburg/5/99 | £120.00 |
00/548 | Influenza Antigen A/Singapore/1/57 (H2N2) | £120.00 |
00/552 | Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3) | £120.00 |
00/556 | Influenza anti-B/Johannesburg/5/99/ Serum | £120.00 |
00/572 | Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard) | £147.00 |
00/574 | Interferon Beta SER17 Mutein (Human, rDNA derived) | £132.00 |
00/576 | Interferon Beta (Human, Fibroblast-derived, Glycosylated) | £132.00 |
007SP | Human Anti-Pneumococcal capsule Reference Serum (1st International Standard) | £147.00 |
01/412 | Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody | £132.00 |
01/420 | Interleukin-17 (Human rDNA derived)(WHO Reference Reagent) | £147.00 |
01/450 | Influenza anti B/Guangdong/120/2000 Serum | £120.00 |
01/452 | Influenza anti A/Panama/2007/99 (H3N2) HA serum | £120.00 |
01/506 | Botulinum type F antitoxin, equine | £132.00 |
01/508 | Botulinum type C antitoxin, equine | £132.00 |
01/510 | Botulinum Antitoxin Equine Type D | £132.00 |
01/512 | Botulinum type G antitoxin, equine | £132.00 |
01/514 | Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody | £132.00 |
01/538 | Anti-Meningococcal Serosubtype P1.16 mAb | £132.00 |
01/546 | Influenza Antigen B/Guangdong/120/2000 | £120.00 |
01/600 | Anti-Toxoplasma IgG, Human(International Standard) | £147.00 |
01/602 | Anti-Parvovirus B19, plasma, human(2nd International Standard) | £147.00 |
01/612 | Influenza Virus infectious B/Hawaii/10/01 | £0.00 |
01/614 | Influenza Antigen A/New Caledonia/20/99 | £120.00 |
02/102 | Influenza anti A/Panama/2007/99 Serum | £120.00 |
02/144 | Anti-Meningococcal Serosubtype P1.15 mAb | £132.00 |
02/148 | Anti-Meningococcal Serosubtype P1.4 mAb | £132.00 |
02/178 | Anti-Meningococcal Serosubtype P1.2 mAb | £132.00 |
02/180 | Anti-Meningococcal Serotype P2.2a mAb | £132.00 |
02/182 | Anti-Japanese Encephalitis Virus Plasma, Human | £132.00 |
02/184 | Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human | £132.00 |
02/210 | HIV (antibody), 1st International Reference Panel | £300.00 |
02/226 | IVIG negative control for use with IVIG + anti-D(WHO Reference Reagent) | £147.00 |
02/228 | IVIG + anti-D for use with negative control IVIG(WHO Reference Reagent) | £147.00 |
02/230 | Biotinylated Brad-5 (Bio-Brad-5) | £35.00 |
02/232 | Tetanus Toxoid (Non-Adsorbed) | £132.00 |
02/286 | Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(WHO Reference Reagent) | £147.00 |
02/294 | Influenza Antiserum A/chick/Italy/1347/99 (H7N1) | £120.00 |
02/308 | Anti-Meningococcal Serotype P3.4 mAb | £132.00 |
02/310 | Anti-Meningococcal Serotype P3.15 mAb | £132.00 |
02/318 | Botulinum Antitoxin Equine Type E | £132.00 |
02/320 | Anti-Meningococcal Serosubtype P1.3 mAb | £132.00 |
02/336 | Influenza Antigen A/New Caledonia/20/99 | £120.00 |
02/338 | Influenza anti A/Panama/2007/99 Serum | £120.00 |
02/342 | Protein C Plasma, Human(2nd International Standard) | £147.00 |
03/104 | HTLV-1 (antibody) Monitor Sample | £35.00 |
03/110 | Influenza anti B/Shangdong/9/97 Serum | £120.00 |
03/114 | Anti-Meningococcal Serosubtype P1.1 mAb | £132.00 |
03/124 | Thrombopoietin ( Human rDNA derived) | £132.00 |
03/142 | Anti-Meningococcal Serosubtype P1.14 mAb | £132.00 |
03/148 | Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st WHO Reference Reagent) | £147.00 |
03/150 | Keratinocyte Growth Factor (KGF,FGF-7)(1st WHO Reference Reagent) | £147.00 |
03/152 | Anti-HPA-1a (International Standard) | £147.00 |
03/164 | Anti-B minimum potency reference preparation(International Standard) | £147.00 |
03/178 | Vitamin B12, Serum Folate and holoTC (International standard) | £147.00 |
03/182 | Anti-Meningococcal Serotype P3.21 mAb | £132.00 |
03/188 | Anti-A minimum potency reference preparation(International Standard) | £147.00 |
03/190 | Anti-HPA-3a(minimum potency)(WHO Reference Reagent) | £147.00 |
03/192 | Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard) | £147.00 |
03/200 | Interleukin - 18 (Human rDNA derived)(WHO Reference Reagent) | £147.00 |
03/210 | Anti-Meningiococcal Serosubtype P1.6 mAb | £132.00 |
03/212 | Influenza anti A/Wyoming/03/03 Serum | £120.00 |
03/220 | Influenza Antigen A/Wyoming/03/03 | £120.00 |
03/224 | Anti-Meningococcal Serosubtype P1.10 mAb | £132.00 |
03/226 | Anti-Meningococcal Serosubtype P1.5 mAb | £132.00 |
03/228 | Protein S, Plasma, Human(2nd International Standard) | £147.00 |
03/236 | Anti-Meningococcal Serosubtype P1.13 mAb | £132.00 |
03/242 | Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum | £120.00 |
03/244 | Influenza Antiserum A/chick/Germany/N/49 | £120.00 |
03/258 | Influenza Antigen A/New Caledonia/20/99 (IVR-116) | £120.00 |
03/262 | Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel) | £300.00 |
04/122 | Anti-Meningococcal Serosubtype P1.12 mAb | £132.00 |
04/160 | Influenza Virus infectious NYMC X-147 | £0.00 |
04/166 | TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st WHO Reference Reagent) | £147.00 |
04/170 | Influenza Virus infectious A/Wellington/1/2004 | £0.00 |
04/172 | Influenza Virus infectious IVR-139 | £0.00 |
04/176 | Plasmodium falciparum DNA for NAT Assays(1st International Standard) | £147.00 |
04/198 | Anti-Meningococcal Serotype P3.1 mAb | £132.00 |
04/202 | Influenza Antigen B/ Jiangsu/10/2003 | £120.00 |
04/224 | Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004 | £300.00 |
04/228 | Influenza anti B/ Neuraminidase Serum | £120.00 |
04/242 | Influenza anti B/Jiangsu/10/2003 HA Serum | £120.00 |
04/246 | Anti-Meningococcal Serogroup W-135 mAb | £132.00 |
04/248 | Anti-Meningococcal Serosubtype P1.19 mAb | £132.00 |
04/252 | Protein C Concentrate, Human(1st International Standard) | £147.00 |
04/260 | Influenza anti A/New Caledonia/20/99 HA Serum | £120.00 |
04/262 | Influenza anti A/New York/55/2004 HA Serum | £120.00 |
04/264 | Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157) | £120.00 |
05/102 | Influenza Virus infectious NYMC BX-7 | £0.00 |
05/106 | Anti-HPA-1a minimum potency reagent(2nd WHO Reference reagent) | £147.00 |
05/112 | Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard). | £147.00 |
05/130 | Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005) | £300.00 |
05/134 | Anti-human papillomavirus type 16 serum (1st International Standard) | £147.00 |
05/162 | Alpha-1-Antitrypsin, plasma derived(1st International standard) | £147.00 |
05/190 | Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody | £132.00 |
05/192 | Anti Meningococcal Serotype P2.2b Monoclonal Antibody | £132.00 |
05/234 | Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142) | £120.00 |
05/236 | Influenza anti A/Wisconsin/67/2005 Serum | £120.00 |
05/252 | Influenza anti B Neuraminidase Serum | £120.00 |
06/108 | Influenza Virus infectious IVR-116 | £0.00 |
06/124 | Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard) | £147.00 |
06/128 | Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard) | £147.00 |
06/140 | Pertussis Antiserum(human)1st IS-WHO international Standard. | £147.00 |
06/142 | Pertussis Antiserum (Human) 1st WHO Reference Reagent | £147.00 |
06/164 | Influenza Virus infectious 1 VR-142 | £0.00 |
06/166 | Antithrombin Concentrate, Human (3rd International Standard) | £147.00 |
06/170 | Influenza Antigen A/New Caledonia/20/99 | £120.00 |
06/192 | Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466) | £120.00 |
06/202 | Human Papillomavirus (HPV) Type 16 DNA (1st International Standard) | £147.00 |
06/206 | Human Papillomavirus (HPV) Type 18 DNA (1st International Standard) | £147.00 |
06/242 | Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR) | £0.00 |
0688 | SARS CoV-1 spike S1 protein | £100.00 |
07/102 | Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145) | £120.00 |
07/104 | Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum | £120.00 |
07/112 | Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 | £120.00 |
07/144 | Influenza Virus infectious IVR-145, | £0.00 |
07/146 | Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep) | £120.00 |
07/148 | Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum | £120.00 |
07/150 | Human Plasma Anti-Influenza H5N1 (1st International Standard) | £147.00 |
07/164 | Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard) | £147.00 |
07/184 | Influenza anti B/Malaysia/2506/2004-HA Serum | £120.00 |
07/202 | Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent) | £147.00 |
07/216 | Diphtheria Toxoid (Adsorbed) (4th International Standard) | £147.00 |
07/222 | RhD/SRY Plasma DNA sensitivity standard (1st WHO Reference Reagent) | £147.00 |
07/228 | Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard” | £147.00 |
07/270 | BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent) | £147.00 |
07/272 | BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent) | £147.00 |
07/274 | BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent) | £147.00 |
07/278 | Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475) | £120.00 |
07/286 | Monitor sample for HBsAg 0.05IU/ml | £35.00 |
07/288 | Hepatitis B Surface Antigen (HBsAg) British Working Standard 0.2 IU/ml | £35.00 |
07/290 | Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6 | £120.00 |
07/296 | Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques | £35.00 |
07/298 | Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques | £35.00 |
07/300 | Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques | £35.00 |
07/306 | Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (WHO Reference Reagent) | £147.00 |
07/316 | Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.) | £147.00 |
07/318 | Meningococcal Group C Polysaccharide | £132.00 |
07/328 | Unfractionated Heparin (6th I.S.) | £147.00 |
07/336 | Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60 | £120.00 |
07/338 | Influenza antiserum A/Anhui/1/05 (H5) | £120.00 |
07/348 | Influenza Virus infectious NYMC X-171B | £0.00 |
07/350 | Blood Coagulation Factor VIII Concentrate (8th I.S.) | £147.00 |
07/358 | Influenza Virus infectious NIB-50 | £0.00 |
07/362 | Influenza Virus infectious IVR-149 | £0.00 |
07/B498 | QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1 | £99.00 |
08/100 | Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1) | £120.00 |
08/108 | Influenza Virus Infectious NIBRG-91 (H9N2) | £0.00 |
08/126 | Influenza Anti N1 Neuraminidase Serum SH485 | £120.00 |
08/138 | Influenza Virus Infectious B/Florida/4/2006 | £0.00 |
08/140 | Influenza Antigen B/Florida/4/2006 | £120.00 |
08/142 | Influenza antiserum A/Anhui/1/05 (H5) | £120.00 |
08/154 | Influenza Virus Infectious NIBRG-12 (H5N1) | £0.00 |
08/156 | Influenza Virus Infectious NIBRG-23 30060 VE3 (H5N1) | £0.00 |
08/158 | Fragile X Syndrome gDNA (1st International Genetic Reference Panel) | £300.00 |
08/160 | Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel) | £300.00 |
08/174 | Human Coxsackie B4 for Nucleic Acid Amplification Techniques | £35.00 |
08/178 | Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques | £35.00 |
08/184 | Influenza Antigen B/Malaysia/2506/2004 | £120.00 |
08/202 | Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1) | £120.00 |
08/204 | Thyroid Stimulating Antibody (2nd I.S.) | £147.00 |
08/208 | Influenza Antigen A/HongKong/1073/99 (H9N2) | £120.00 |
08/210 | Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86) | £120.00 |
08/214 | Meningococcal Serogroup C polysaccharide (1st International Standard) | £147.00 |
08/216 | Influenza Antigen A/Cambodia/RO405050/2007 (H5N1) | £120.00 |
08/218 | Tetanus Toxoid Adsorbed (4th International Standard) | £147.00 |
08/228 | Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91 | £120.00 |
08/230 | Streptodornase (2nd International Standard) | £147.00 |
08/246 | Influenza anti A/Brisbane/10/2007- like HA serum | £120.00 |
08/248 | Influenza Virus Infectious NIBRG-107 VE2 30480 | £0.00 |
08/250 | Influenza Virus Infectious NIBRG-63 VE2 30500 (H7N1) | £0.00 |
08/252 | Influenza Virus Infectious NIBRG-109 VE2 30490 | £0.00 |
08/256 | C1- Inhibitor, Concentrate (1st International Standard) | £147.00 |
08/258 | Antithrombin, Plasma (3rd International Standard) | £147.00 |
08/262 | C1 Inhibitor (Plasma)(1st International Standard) | £147.00 |
08/266 | Sex Hormone Binding Globulin.(2nd International Standard) | £147.00 |
08/268 | Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107 | £120.00 |
08/278 | Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C)) | £120.00 |
08/298 | Influenza Virus Infectious B/Brisbane/33/2008 30720 E5 | £0.00 |
08/300 | Influenza Virus Infectious IVR-148 | £0.00 |
08/304 | Influenza virus infectious NYMC X-175C | £0.00 |
08/322 | Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing | £35.00 |
08/324 | Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing | £35.00 |
08/356 | Influenza antiserum A/Japan/305/57 (H2) | £120.00 |
08/362 | Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109 | £120.00 |
09/100 | Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503) | £120.00 |
09/110 | Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard) | £300.00 |
09/130 | Influenza Virus Infectious NIBRG-122 | £0.00 |
09/136 | Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard) | £147.00 |
09/138 | Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.) | £300.00 |
09/140 | Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel) | £300.00 |
09/148 | Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505) | £120.00 |
09/162 | Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard) | £147.00 |
09/170 | Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody | £132.00 |
09/172 | Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010) | £147.00 |
09/174 | Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived) | £120.00 |
09/182 | VWF Factor Concentrate (2nd International Standard) | £147.00 |
09/184 | Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14 | £120.00 |
09/186 | Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard) | £147.00 |
09/188 | Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard) | £147.00 |
09/196 | Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived) | £120.00 |
09/222 | Human anti-Haemophilus influenzae b reference serum | £132.00 |
09/234 | Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard) | £147.00 |
09/236 | Influenza Virus Infectious IVR-153 | £0.00 |
09/242 | Fibrinogen Concentrate (B)(2nd International Standard) | £147.00 |
09/260 | Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard) | £147.00 |
09/264 | Fibrinogen Plasma (D)(3rd International Standard) | £147.00 |
09/266 | GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived | £132.00 |
09/268 | Influenza Virus Infectious NIBRG-121xp | £0.00 |
09/272 | Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1) | £132.00 |
09/274 | Influenza Virus Infectious NYMC X-185 | £0.00 |
09/280 | Influenza Virus Infectious NIB-64 | £0.00 |
09/284 | Anti-Human Neutrophil Antibody 1a WHO Reference Reagent | £147.00 |
09/296 | Pro-Insulin, human (1st International Standard) | £147.00 |
09/304 | Influenza Virus Infectious IVR-155 | £0.00 |
09/308 | Influenza Serology Antigen Reagent X-179A (H1N1pdm) for HI Assay | £132.00 |
09/310 | Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183) | £120.00 |
10/104 | Reteplase Reference Material | £132.00 |
10/120 | Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum | £120.00 |
10/128 | Diphtheria Polyclonal Antibody | £132.00 |
10/130 | Diphtheria Monoclonal Antibody | £132.00 |
10/132 | Tetanus Polyclonal Antibody | £132.00 |
10/134 | Tetanus Monoclonal Antibody | £132.00 |
10/140 | Anti-human papillomavirus[HPV] 18 serum (1st International Standard) | £147.00 |
10/164 | Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain]. | £34.00 |
10/168 | Oral Poliovaccine Sabin Type 3 reference | £34.00 |
10/176 | Interleukin-29 (Interferon Lambda, Human, rDNA derived) WHO Reference Reagent | £147.00 |
10/178 | Endotoxin (3rd International Standard) | £147.00 |
10/198 | Anti-malaria (Plasmodium falciparum) human serum(1st WHO Reference Reagent) | £147.00 |
10/202 | Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard) | £147.00 |
10/214 | Influenza Anti N2 Neuraminidase Serum SH395 & SH396 | £120.00 |
10/218 | Influenza Anti A/California/7/2009 (N1) NA Serum | £120.00 |
10/226 | Influenza Virus Infectious IVR-158 | £0.00 |
10/232 | Blood Group Genotyping Reference Reagent RBC1 (OR1R2)(WHO Reference Reagent) | £147.00 |
10/234 | Blood Group Genotyping Reference Reagent RBC12 (ODpsi)(WHO Reference Reagent) | £147.00 |
10/236 | Blood Group Genotyping Reference Reagent RBC4 (AR1R1)(WHO Reference Reagent) | £147.00 |
10/238 | Blood Group Genotyping Reference Reagent RBC5 (Brr)(WHO Reference Reagent) | £147.00 |
10/242 | Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard) | £147.00 |
10/252 | Factor VII Concentrate (2nd International Standard) | £147.00 |
10/258 | Influenza Antigen A/California/7/2009-like(NIB-74) | £120.00 |
10/262 | Diphtheria Antitoxin Human IgG(1st International Standard) | £147.00 |
10/272 | BCG vaccine of Moreau-RJ sub-strain(1st WHO Reference Reagent) | £147.00 |
10/286 | Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard) | £147.00 |
100976 | pCAGGS-SARS-CoV-2-Spike | £50.00 |
100978 | VeroE6/TMPRSS2 | £50.00 |
100980 | SARS-CoV-2 infectious virus (BetaCoV/Australia/VIC01/2020 | £50.00 |
100985 | pCAGGS_SARS-CoV-2_Spike D614G | £50.00 |
100986 | pCAGGS-SARS-CoV-2-Spike Bristol Deletion | £50.00 |
100987 | Inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020 | £50.00 |
100988 | Nucleic acid extracts from inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020 | £50.00 |
100989 | pCRII-SARS-CoV-2 (5'UTR-NSP2) | £50.00 |
100991 | pCRII-SARS-CoV-2 (NSP4-NSP8) | £50.00 |
100992 | pCRII-SARS-CoV-2 (NSP4-NSP8) | £50.00 |
100994 | pCRII-SARS-CoV-2 (NSP15-NSP16) | £50.00 |
100996 | pCRII-SARS-CoV-2 (ORF3a-ORF6) | £50.00 |
100998 | SARS-CoV-2 infectious virus (CVR-GLA 1) | £50.00 |
100999 | SARS-CoV-2 infectious virus(CVR-GLA 2) | £50.00 |
101000 | SARS-CoV-2 infectious virus(CVR-GLA 3) | £50.00 |
101001 | VeroE6-ACE2 | £50.00 |
101003 | VeroE6-ACE2-TMPRSS2 | £50.00 |
101004 | A549-ACE2-TMPRSS2 | £50.00 |
101005 | A549-ACE2 Clone8 | £50.00 |
101006 | A549-ACE-2 Clone 8-TMPRSS2 | £50.00 |
101007 | SARS-CoV-2 Trimeric Spike 50ug (1mg/ml in PBS) Sterile #28.05.2020 | £100.00 |
101008 | HEK293T-ACE2-TMPRSS2 | £50.00 |
101009 | Anti-SARS-CoV-2 Nucleocaspid protein (CR3009) | £50.00 |
101010 | Anti-SARS-CoV-2 Nucleocapsid protein (CR3018) | £50.00 |
101011 | Anti-SARS-CoV-2 Nucleocapsid protein (CR3009 Human/Mouse HC) | £50.00 |
101019 | VOC-202012/01 (B.1.1.7 lineage) lot 26012021 | £50.00 |
101022 | SARS-CoV-2 VOC202012/02 (B.1.351 lineage) passage 4 | £50.00 |
101023 | pl.18SARS-CoV-2-Spike (B.1.1.7) 1ug (100ng/ul) lot #24032021 | £50.00 |
101024 | pl. 18SARS-CoV-2-Spike (B.1.351) 1ug (100ng/ul) lot #24032021 | £50.00 |
101025 | 4% formaldehyde inactivated SARS CoV-2 BetaCoV/Australia/VIC01/2020 from VeroE6/TMPRSS2 | £50.00 |
101027 | Acid/heat inactivated SARS-CoV-2 (B.1.1.7) lot 17022021 | £50.00 |
101029 | SARS-CoV-2 Alpha (B.1.1.7) Purified RNA extracts lot 20052021 | £50.00 |
101030 | SARS-CoV-2 VOC-202104/02 (B.1.617.2 lineage) | £50.00 |
101031 | SARS-CoV-2 VOC-21FEB02 (B.1.1.7 lineage + E484K) | £50.00 |
101032 | SARS-CoV-2 Kappa (B.1.617.1 lineage | £50.00 |
101033 | SARS-CoV-2 Delta (AY.1 sub-lineage) | £50.00 |
101034 | SARS-CoV-2 Mu (B.1.621 lineage) | £50.00 |
101035 | Acid/Heat Inactivated SARS-CoV-2 Beta (B.1.351 lineage) | £50.00 |
101036 | Acid/Heat Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage | £50.00 |
101037 | Inactivated (acetic acid + heat) SARS-CoV-2 Gamma (P.1 lineage) | £50.00 |
101038 | 0.01% Formaldehyde Inactivated SARS-CoV-2 Beta (B.1.351 lineage) | £50.00 |
101039 | 0.01% Formaldehyde Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage) | £50.00 |
101042 | SARS-CoV-2 Nucleocapsid protein (His tagged) | £100.00 |
101043 | SARS-CoV-2 Nucleocapsid protein 203/204:RG>KR (His tagged) | £100.00 |
101044 | SARS-CoV-2 Omicron (lineage B.1.1.529) | £50.00 |
101047 | Inactivated (Acetic Acid + Heat)SARS-CoV-2 Omicron (BA.1 sublineage) | £50.00 |
101054 | SARS-CoV-2 Omicron BA.1.1 sublineage lot 28032022 | £50.00 |
101055 | SARS-CoV-2 Omicron (BA.2) | £50.00 |
101062 | HEK293T-ACE2-30F-PLP2 | £50.00 |
1050 | IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050) | £315.00 |
11/108 | Influenza Virus infectious NYMC X-187 | £0.00 |
11/126 | Factors II and X Concentrate (4th International standard) | £147.00 |
11/134 | Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived) | £120.00 |
11/170 | Erythropoietin, recombinant, for Bioassay (3rd International Standard) | £147.00 |
11/176 | (3rd International Standard) Low Molecular Weight Heparin | £147.00 |
11/184 | High Molecular Weight Urokinase(2nd International Standard) | £147.00 |
11/206 | Influenza anti-A/Perth/16/2009 HA Serum | £120.00 |
11/210 | Anti-human CD4 FITC conjugated 0.5ml | £132.00 |
11/212 | Biosynthetic Human Insulin (2nd WHO international Standard) | £147.00 |
11/214 | Blood Group Genotyping Reference Reagents Panel (WHO Reference Reagent) | £300.00 |
11/216 | Chagas Antibody Reference Panel ( 1st International Standard) | £300.00 |
11/222 | Influenza Virus Infectious NIB-79 | £0.00 |
11/232 | Influenza Virus Infectious B/Texas/6/2011 | £0.00 |
11/234 | Immunoglobulin E(IgE) human serum (3rd International Standard) | £147.00 |
11/242 | Viral Multiplex Reference | £132.00 |
11/244 | Influenza Virus Infectious NYMC BX-49 | £0.00 |
11/B608 | QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1 | £99.00 |
12/100 | Influenza Virus Infectious NYMC X-217 | £0.00 |
12/104 | International Standard for IPV 12/104 (3rd International Standard) | £147.00 |
12/106 | Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39) | £120.00 |
12/110 | Influenza Antigen B/Wisconsin/1/2010 (cell derived) | £120.00 |
12/112 | Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187) | £120.00 |
12/114 | Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165) | £120.00 |
12/116 | Influenza anti-A/Victoria/361/2011-like HA serum | £120.00 |
12/118 | Influenza anti-B/Wisconsin/1/2010-like HA serum | £120.00 |
12/122 | Influenza virus infectious A/turkey/Italy/3889/1999 (H7N1) | £0.00 |
12/154 | Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard) | £147.00 |
12/176 | Methylated Human Serum Albumin (mHSA) | £132.00 |
12/188 | Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (1st International Standard) | £147.00 |
12/198 | Influenza virus infectious B/Wisconsin/1/2010 34490 E5 | £0.00 |
12/202 | Influenza virus infectious NYMC BX-39 | £0.00 |
12/204 | Influenza Virus infectious IVR-165 | £0.00 |
12/208 | Parvovirus B19 (3rd International Standard) | £147.00 |
12/224 | HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation) | £357.00 |
12/226 | HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard) | £147.00 |
12/244 | Vi polysaccharide of C freundii WHO 1st International Standard | £147.00 |
12/250 | Influenza anti A/Mallard/England 727/2006 (H2) HA Serum | £120.00 |
12/252 | ADAMTS 13 Plasma (1st International Standard) | £147.00 |
12/278 | 2nd Pneumococcal QC Serum Panel | £300.00 |
12/282 | Diphtheria Toxin 1Lf/ml | £132.00 |
12/284 | Anti-meningococcal serogroup Y monoclonal antibody | £132.00 |
12/290 | Influenza Virus Infectious B/Brisbane/36/2012 | £0.00 |
12/294 | Influenza Virus Infectious NYMC BX-51C | £0.00 |
12/300 | Negative Control IVIG (for use with IVIG and Anti-D) | £132.00 |
12/306 | Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard) | £147.00 |
12/B612 | QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1 | £99.00 |
13/100 | Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard) | £147.00 |
13/106 | Influenza Antigen B/Massachusetts/02/2012 | £120.00 |
13/108 | Anti-Meningococcal serogroup B monoclonal antibody | £132.00 |
13/112 | Influenza Antigen A/Texas/50/2012 (NYMC X-223) | £120.00 |
13/116 | Influenza Antigen A/Texas/50/2012 (NYMC X-223A) | £120.00 |
13/122 | Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel) | £147.00 |
13/126 | Influenza anti-B/Brisbane/60/2008-like HA serum | £120.00 |
13/128 | Influenza Virus Infectious NIBRG-269 | £0.00 |
13/132 | Antibodies, Human, to Toxoplasma gondii (4th International Standard). | £147.00 |
13/134 | Influenza Antigen B/Massachusetts/02/2012 (Egg derived) | £120.00 |
13/146 | C-Peptide, Human (1st International Standard). | £147.00 |
13/148 | IVIG + anti-D for use with negative control IVIG | £132.00 |
13/152 | Influenza Antigen B/Massachusetts/02/2012 (Cell Derived) | £120.00 |
13/162 | Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived) | £120.00 |
13/164 | Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A) | £120.00 |
13/166 | Influenza anti-A/Anhui/1/2013 (N9) NA Serum | £120.00 |
13/172 | Lupus Anticoagulant (1st International Reference Panel) | £300.00 |
13/176 | Influenza Virus Infectious NIBRG-88 | £0.00 |
13/178 | Influenza Anti-A/Texas/50/2012-like HA Serum | £120.00 |
13/182 | Influenza Anti-B/Massachusetts/02/2012-like HA Serum | £120.00 |
13/200 | Influenza Virus Infectious NIB-74 | £0.00 |
13/202 | Influenza Virus Infectious NIB-74xp | £0.00 |
13/204 | TNF Rec II- FC Fusion protein (1st International Standard) | £147.00 |
13/206 | Plasmin (4th International Standard) | £147.00 |
13/212 | Diphtheria Toxoid for use in Flocculation Test (3rd International Standard) | £147.00 |
13/214 | HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel) | £357.00 |
13/216 | Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal | £132.00 |
13/218 | Polio Anti Sabin type 1 (inactivated) Serum | £132.00 |
13/220 | Polio Anti Sabin type 2 (inactivated) serum | £132.00 |
13/222 | Polio Anti Sabin type 3 (inactivated) serum | £132.00 |
13/224 | Influenza virus Infectious NIB-85. 36210 E5 | £0.00 |
13/228 | Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4 | £0.00 |
13/234 | Influenza antigen B/Brisbane/60/08 | £120.00 |
13/238 | Anti-EV71 serum LOW (WHO Reference Reagent) | £147.00 |
13/240 | Tetanus Immunoglobulin, Human (2nd WHO International Standard) | £147.00 |
13/242 | FEIBA Concentrate 2nd NIBSC Working Reference Standard | £35.00 |
13/246 | Meningococcal serogroup A polysaccharide (1st WHO International Standard). | £147.00 |
13/248 | Influenza virus infectious NIBRG-267 (H7N9) | £0.00 |
13/250 | Influenza Virus Infectious NIBRG-268 (H7N9) | £0.00 |
13/252 | Influenza virus infectious NYMC X-223A | £0.00 |
13/256 | Influenza virus infectious. NYMC x-233 | £0.00 |
13/258 | Influenza virus infectious NYMC X-233A | £0.00 |
13/262 | Meningococcal serogroup A polysaccharide | £132.00 |
13/264 | Influenza Virus Infectious NYMC X-223 | £0.00 |
13/B627 | QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1 | £99.00 |
13/B629 | QCRHBeQC1 Anti-HBe Control Serum: sample1 | £99.00 |
13/B634 | QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2 | £99.00 |
13/B640 | QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5 | £99.00 |
13/B642 | QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1 | £99.00 |
13/B644 | QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3 | £99.00 |
14/100 | Human Papillomavirus (HPV) 11 DNA (1st International Standard) | £147.00 |
14/104 | Human Papillomavirus (HPV) Type 45 DNA (1st International Standard) | £147.00 |
14/106 | Influenza virus infectious. NYMC BX-51B | £0.00 |
14/114 | JC Virus (JCV) DNA (1st International Standard) | £147.00 |
14/116 | Influenza virus infectious NYMC X-179A | £0.00 |
14/118 | Influenza virus infectious B/Massachusetts/2/2012 | £0.00 |
14/140 | 1st International Standard for Anti EV71 Serum Human | £147.00 |
14/144 | Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011) | £120.00 |
14/146 | Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived) | £120.00 |
14/148 | Human Blood Factor IX Concentrate (5th International Standard). | £147.00 |
14/156 | Meningococcal group X polysaccharide (1st WHO International Standard) | £147.00 |
14/160 | High titre anti-A in IVIG working reference reagent | £35.00 |
14/174 | Botulinum Type A Antitoxin, Equine | £132.00 |
14/200 | Influenza Antigen A/Puerto Rico/8/34 (HINI) | £120.00 |
14/206 | Influenza virus infectious NYMC X-247 | £0.00 |
14/210 | Biological activities of Rituximab WHO 1st International Standard | £147.00 |
14/212 | BK Virus (BKV)(1st International Standard) | £147.00 |
14/224 | Influenza virus infectious. A/Switzerland/9715293/2013 | £0.00 |
14/226 | Influenza Virus Infectious A/South Australia/55/2014 | £0.00 |
14/228 | Influenza Virus Infectious A/Stockholm/6/2014 | £0.00 |
14/230 | Influenza Virus Infectious. A/Norway/466/2014 | £0.00 |
14/232 | Influenza Virus Infectious IVR-175 | £0.00 |
14/238 | Recombinant Tissue factor | £35.00 |
14/254 | Influenza Antigen A/Switzerland/9715293/2013 (NIB88) | £120.00 |
14/256 | Human Papillomavirus (HPV) Type 6 DNA (1st International Standard) | £147.00 |
14/258 | Human Papillomavirus (HPV) Type 31 DNA (1st International Standard) | £147.00 |
14/260 | Human Papillomavirus (HPV) Type 33 DNA (1st International Standard) | £147.00 |
14/262 | Human Papillomavirus (HPV) Type 52 DNA (1st International Standard) | £147.00 |
14/264 | Human Papillomavirus (HPV) Type 58 DNA (1st International Standard) | £147.00 |
14/274 | Influenza Antigen B/Brisbane/9/2014 (Egg Derived) | £120.00 |
14/300 | High titre anti-A and anti-B in serum (WHO Reference Reagent). | £147.00 |
14/306 | Influenza Virus Infectious NYMC X-243 40180 E13 | £0.00 |
14/308 | Influenza Virus Infectious IVR-178 40200 E7 | £0.00 |
14/314 | Influenza Virus Infectious NIB-88 | £0.00 |
14/316 | Factor IX activated (FIXa) 2nd WHO International Standard | £147.00 |
14/318 | Influenza Anti NIBRG-301 (H5) HA Serum (Sheep SH624 and SH625) | £120.00 |
14/322 | Influenza Virus Infectious NIB-91 | £0.00 |
14/B651 | QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2 | £99.00 |
14/B653 | QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3 | £168.00 |
14/B654 | QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1 | £154.00 |
14/B655 | QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1 | £99.00 |
15/100 | Influenza Antigen B/Utah/9/2014 (Cell Derived) | £120.00 |
15/102 | Activated Blood Coagulation Factor X (FXa), Human | £147.00 |
15/104 | Influenza Antigen A/South Australia/55/2014 Cell derived | £120.00 |
15/106 | Ancrod | £147.00 |
15/126 | Bordetella pertussis toxin (20µg). (2nd International Standard) | £147.00 |
15/130 | Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT) | £35.00 |
15/134 | Influenza Anti-A Switzerland/9715293/2013-Like HA serum | £120.00 |
15/136 | EBOV RNA NP-VP35-GP in-run control | £147.00 |
15/138 | EBOV RNA VP40-L in-run control | £147.00 |
15/140 | Batroxobin | £126.00 |
15/148 | Influenza Virus Infectious NIB-92 | £0.00 |
15/154 | Influenza Virus Infectious NIB-93 | £0.00 |
15/158 | Influenza Virus Infectious NYMC X-263 | £0.00 |
15/160 | Influenza Virus Infectious NIBRG-306 | £0.00 |
15/174 | Lupus (oligo-specific) anti-dsDNA antibodies WHO Reference Reagent | £147.00 |
15/180 | Blood Coagulation Factor XI, 2016 Plasma Human (2nd International Standard). Blood Coagulation Factor XII, 2017 Plasma, Human (1st International Standard) | £147.00 |
15/182 | 7th British Working Standard for Blood Coagulation Factors II, IX, X Concentrate | £35.00 |
15/184 | Influenza Virus Infectious NYMC X-263B | £0.00 |
15/188 | Influenza Virus Infectious NYMC X-263A | £0.00 |
15/194 | Influenza Virus Infectious NYMC X-257A | £0.00 |
15/196 | Influenza Virus Infectious NYMC X-261 | £0.00 |
15/212 | Influenza Virus Infectious NYMC BX-53C | £0.00 |
15/220 | Anti-EBOV plasma, human (WHO Reference Reagent) | £147.00 |
15/222 | EBOV RNA NP-VP35-GP (WHO Reference Reagent) | £147.00 |
15/224 | EBOV RNA VP40-L (WHO Reference Reagent) | £147.00 |
15/234 | Influenza Virus Infectious B/Texas/2/2013 41340 E7 | £0.00 |
15/238 | Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen) | £120.00 |
15/240 | Erythropoietin Antibody Reference Panel A (1st WHO Reference Panel) | £541.00 |
15/242 | Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel) | £462.00 |
15/248 | Influenza Anti A/Anhui/1/2013 (H7) HA Serum (Sheep SH644 & SH645) | £120.00 |
15/250 | Influenza Virus Infectious NYMC BX-31 | £0.00 |
15/252 | Influenza Virus Infectious A/California/7/2009 | £0.00 |
15/262 | 1st International Standard for Ebola virus (EBOV) antibodies Sierra Leone Convalescent Plasma Pool | £147.00 |
15/266 | HHV-6 Virus 1st WHO International Standard | £147.00 |
15/270 | CD4 WHO Reference Reagent | £147.00 |
15/272 | ICS Positive Control-Lymphocytes | £132.00 |
15/276 | Hepatitis A Virus VL For Nucleic Acid Amplification Techniques (3rd International Standard) | £147.00 |
15/294 | Influenza virus infectious NYMC BX-59B | £0.00 |
15/296 | Sabin monovalent Polio vaccine type 2 (1st International Standard) | £147.00 |
15/298 | Influenza Virus Infectious B/Brisbane/46/2015 | £0.00 |
15/300 | Influenza Virus Infectious NYMC BX-35 41950 E11 | £0.00 |
15/304 | Parathyroid hormone 1-34, recombinant, human, 2nd WHO International Standard | £147.00 |
15/B658 | QCRLYMEQC1 - Anti-Lyme QC1 | £99.00 |
15/B664 | QCRMUMPSQC1 - Anti-Mumps Quality Control Reagent Sample 1 | £99.00 |
15/B667 | QCRMEASQC1 Anti-Measles QC1 | £99.00 |
15/B671 | QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1 | £117.00 |
15/B678 | QCRPARVB19QC1 Anti-Parvovirus B19QC1 | £99.00 |
16/104 | Norovirus GII Working reagent for Nucleic Acid Amplification Techniques | £35.00 |
16/106 | Influenza antigen A/California/7/09 (H1N1) (NYMC-X181) | £120.00 |
16/108 | Influenza Virus Infectious A/PR/8/34 | £0.00 |
16/110 | Zika Virus Working Reagent for Nucleic Acid Amplification Testing (NAT) | £35.00 |
16/114 | Influenza anti - A/California/7/09 HA serum | £120.00 |
16/118 | Influenza Antigen B/Brisbane/60/2008 (NYMC BX-35) (Egg Derived) | £120.00 |
16/120 | WHO 1st International Reference Panel for Genomic JAK2 V617F | £300.00 |
16/126 | Native Vi polysaccharide (S. Typhi) (1st International Standard) | £147.00 |
16/138 | Anti-Typhoid capsular Vi polysaccharide Ig (Human) 1st WHO International Standard | £147.00 |
16/152 | Meningococcal Serogroup W Polysaccharide | £147.00 |
16/164 | Sabin bivalnet Polio vaccines types 1 and 3 (1st International Standard) | £147.00 |
16/170 | Infliximab (1st International Standard) | £147.00 |
16/182 | Influenza Anti-A/Hong Kong/4801/2014-like HA Serum | £120.00 |
16/190 | Mullerian Inhibiting Substance/Anti-Mullerian Hormone, human, recombinant (WHO reference Reagent) | £147.00 |
16/192 | Influenza Anti - B/Brisbane/60/2008-HA serum | £120.00 |
16/194 | HIV-1 RNA (4th International Standard) | £147.00 |
16/196 | Sabin monovalent Polio vaccine type 1(1st International Standard) | £147.00 |
16/200 | Influenza Virus Infectious NIB-58 | £0.00 |
16/202 | OPV reference mOPV 3 | £147.00 |
16/204 | 7th WHO International Standard for Rabies Vaccine | £147.00 |
16/206 | Meningococcal serogroup Y Polysaccharide | £147.00 |
16/208 | Influenza Virus Infectious NIB-97 42090 E7 | £0.00 |
16/210 | HIV-1 P24 Antigen (1st international reference panel) | £299.00 |
16/236 | HIV-2 p26 Antigen (VLP)-HIV-2 A7312 (1st WHO Reference Reagent) | £147.00 |
16/238 | Influenza Antigen A/Anhui/1/2013 (NIBRG-268) (H7N9) | £120.00 |
16/242 | Influenza Virus Infectious NIB-98 42110 E7 | £0.00 |
16/250 | 1st International Reference Panel for genomic KRAS codons 12 and 13 mutations | £300.00 |
16/268 | Influenza Virus Infectious X-273 | £0.00 |
16/270 | Influenza Virus Infectious IVR-180 42400 E3/D7/E1 | £0.00 |
16/274 | Influenza Virus Infectious X-275A 42010 E13 | £0.00 |
16/278 | Anti-D Immunglobulin control preparation | £35.00 |
16/282 | Influenza Virus Infectious X-285 42430 ExE1 | £0.00 |
16/284 | Antiserum to Respiratory Syncytial Virus WHO 1st International Standard | £147.00 |
16/286 | Influenza Antigen A/Hong Kong/4801/2014 (NYMC X-263B) | £120.00 |
16/288 | Influenza Virus Infectious X-283A 42420 ExE1 | £0.00 |
16/290 | Influenza Virus Infectious X-285A 42440 ExE1 | £0.00 |
16/292 | Influenza Antigen A/Singapore/GP1908/2015 (IVR-180) | £120.00 |
16/296 | Human Immunodeficiency Virus type 2 RNA (HIV-2) for Nucleic Acid Amplification Techniques (2nd International Standard) | £147.00 |
16/302 | Tetanus Toxoid for use in Flocculation Test (3rd International Standard) | £147.00 |
16/320 | Zika Antibody Working reagent | £132.00 |
16/324 | Human Adenovirus DNA for nucleic acid amplification techniques (1st WHO international Standard). | £147.00 |
16/332 | Anti-D Immunoglobulin (Replacement IS) | £147.00 |
16/344 | WHO Anti-EBOV Convalescent Plasma (International Reference Panel) | £300.00 |
16/352 | Anti-Asian Lineage Zika Virus Antibody (human) (1st international standard) | £147.00 |
16/358 | Streptokinase (4th WHO International Standard) | £147.00 |
16/360 | Influenza Virus Infectious NIB-96 41920 E7 | £0.00 |
16/362 | Influenza Virus Infectious NYMC X-291 42530 E8 | £0.00 |
16/364 | 3rd International Standard for Prekallikrein Activator | £147.00 |
16/366 | Influenza Virus Infectious NYMC X-291A 42540 E8 | £0.00 |
16/368 | HSV-1 | £147.00 |
16/374 | Blood Coagulation Factor V, Plasma, Human. (WHO 2nd International Standard) | £147.00 |
16/376 | Plasmodium falciparum antigens (1st International Standard) | £147.00 |
16/B687 | QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices | £99.00 |
16/B693 | QCRCMVIgMQC1 IgM Anti-CMV QC1 | £117.00 |
16/B697 | QCREBVVCAQC1 | £106.00 |
16/B704 | QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1 | £99.00 |
16/B707 | QCREBVNEGQC1 | £106.00 |
1-7 | Fimbrae monoclonal antibody, clone 1-7 | £50.00 |
17/100 | Prostate Specific Antigen (human)(total: PSA-ACT + free PSA) | £147.00 |
17/102 | Prostate Specific Antigen (human) (Free), (2nd WHO International Standard) | £147.00 |
17/106 | Influenza Anti-A/Michigan/45/2015-like HA Serum | £120.00 |
17/122 | HSV-2 | £141.00 |
17/124 | Influenza Virus Infectious NYMC BX-63 42790 E10/E1 | £0.00 |
17/126 | Influenza Virus Infectious NYMC BX-63A 42780 E10/E1 | £0.00 |
17/132 | Influenza Anti NIBRG-306 (H5) HA Serum (sheep SH672 and SH637) | £120.00 |
17/136 | Influenza Virus Infectious NIBRG-375 (H7N9) | £0.00 |
17/142 | Influenza Antigen A/Duck Vietnam/NCVD-1584/2012 (NIBRG-301) (H5N1) | £120.00 |
17/154 | Influenza Antigen A/Michigan/45/2015 (NYMC X-275) | £120.00 |
17/156 | Influenza Virus Infectious CNIC-1701 42910 E9 | £0.00 |
17/160 | Sabin Inactivated Polio Vaccine (sIPV) (WHO 1st international Standard) | £147.00 |
17/162 | Influenza Virus Infectious NYMC X-299 42920 E10 | £0.00 |
17/164 | Influenza Virus Infectious B/Maryland/15/2016 42800 E5 | £0.00 |
17/182 | Influenza Antigen A/Michigan/45/2015 (NYMC X-275) | £120.00 |
17/184 | Influenza Virus Infectious NIB-103 42610 E7 | £0.00 |
17/190 | Influenza Virus Infectious NYMC X-297 42940 E11 | £0.00 |
17/194 | Influenza Virus Infectious NIB-104 | £0.00 |
17/204 | 1st International Standard for Darbepoetin | £147.00 |
17/206 | 14th British Standard for Coagulation Factor VIII Concentrate, Human. | £35.00 |
17/210 | Influenza Virus Infectious IVR-186 43310 E8 | £0.00 |
17/232 | Tumor Necrosis Factor alpha (human rDNA derived) | £132.00 |
17/236 | Adalimumab (1st WHO International Standard) | £147.00 |
17/240 | 5% Immunoglobulin (Negative Control) | £132.00 |
17/246 | Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (NIB-104) | £120.00 |
17/252 | Influenza Virus Infectious NYMC BX-69 43220 E13 | £0.00 |
17/256 | Influenza Virus Infectious NYMC BX-69A | £0.00 |
17/258 | Influenza Virus Infectious B/Alabama/2/2017 | £0.00 |
17/264 | Influenza Virus Infectious A/Michigan/45/2015 43470 E5 | £0.00 |
17/B710 | QCRTOXOQC1 - Anti-Toxoplasma gondii Quality Control Reagent Sample 1 | £99.00 |
17/B713 | QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample 2 | £154.00 |
17/B717 | QCRHBsGQC1-HBsAg Quality Control Serum: Sample1 | £99.00 |
17/B723 | QCRHEVQC1 - Anti-Hepatitis E Quality Control Sample 1 | £117.00 |
17/B725 | QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1 | £99.00 |
17/B728 | QCRHEVIgMQC1 - IgM Anti-Hepatitis E Quality Control Sample 1 | £117.00 |
18/100 | Influenza Antigen B/Maryland/15/2016 | £120.00 |
18/104 | Influenza Antigen B/Maryland/15/2016 (NYMC BX-69A) | £120.00 |
18/108 | Influenza anti-A/Singapore/INFIMH-16-0019/2016- like HA serum | £120.00 |
18/110 | Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (IVR-186) | £120.00 |
18/112 | Influenza anti-A/Guangdong-17SF003/2016 (H7) (NIBRG-375) HA Serum | £120.00 |
18/116 | WHO International Standard Enterovirus 71 (EV71) Inactivated vaccine (Geno Group C4) | £147.00 |
18/118 | 1st International Standard for HCT 15 Cancer Genome | £147.00 |
18/120 | WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group C4) | £147.00 |
18/130 | 1st International Standard for MOLT-4 Cancer Genome | £147.00 |
18/132D | WHO Reference Reagent Lentiviral Vector Copy number by digital PCR 6.75 log 10 LV copies/ampoule | £147.00 |
18/132Q | WHO Reference Reagent Lentiviral Vector Copy number by quantitative PCR 6.89 log 10 LV copies/ampoule | £0.00 |
18/134 | Influenza Virus Infectious NIBRG-301 (H5N1) | £0.00 |
18/136 | Influenza Virus Infectious NIBRG-14 (H5N1) | £0.00 |
18/138 | Influenza Virus Infectious NYMC X-307A | £0.00 |
18/140 | Influenza Virus Infectious NYMC X-307 | £0.00 |
18/144 | WHO 1st Reference Reagent for Lentiviral Vector Integration Site Analysis | £147.00 |
18/146 | Pertussis antiserum (human) panel | £314.00 |
18/154 | Bordetella pertussis, pertactin, PRN | £132.00 |
18/156 | WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group B4) | £147.00 |
18/160 | Influenza Virus Infectious NYMC X-311 | £0.00 |
18/164 | 1st International Standard for ATDB102 Genome | £147.00 |
18/166 | Influenza Virus Infectious NIB-112 43990 E6 | £0.00 |
18/168 | Influenza Virus Infectious A/Switzerland/8060/2017 | £0.00 |
18/170 | Influenza anti-B/Colorado/06/2017-like HA serum | £120.00 |
18/174 | Influenza Virus Infectious A/Brisbane/1/2018 | £0.00 |
18/180 | 2nd International Standard for Diphtheria Antitoxin Equine | £147.00 |
18/184 | Hepatitis C virus RNA for nucleic acid amplification techniques (6th WHO International Standard) | £147.00 |
18/188 | Influenza Antigen A / Switzerland / 8060 / 2017 (NIB-112) | £120.00 |
18/190 | Influenza Antigen A / Brisbane/ 01/2018 (NYMC X-311) | £120.00 |
18/192 | Influenza Anti-A/Switzerland/8060/2017-like (H3N2) HA Serum | £120.00 |
18/194 | Influenza Virus Infectious NYMC X-275 (Influenza Reagent) | £0.00 |
18/196 | Influenza Antigen A/Guangdong/17SF003/2016. NIBRG-375 (H7N9) | £120.00 |
18/206 | West Nile Virus - International Standard | £147.00 |
18/208 | WHO Reference Reagent for West Nile Virus lineage 2 RNA for NAT-based assays | £141.00 |
18/210 | Bevacizumab (1st WHO International Standard) | £147.00 |
18/220 | Anti-HPA 15b minimum potency reagent (WHO Reference Reagent) | £147.00 |
18/226 | Influenza Virus Infectious IVR-190 44250 E12 | £0.00 |
18/230 | Influenza Virus Infectious B/Colorado/06/2017 43460 E7 | £0.00 |
18/234 | Influenza Virus Infectious NIB116-B 44230 E5 | £0.00 |
18/236 | Influenza Virus Infectious A/Brisbane/02/2018 | £0.00 |
18/238 | Influenza Antigen A/Brisbane/02/2018 (IVR-190) (H1N1) | £120.00 |
18/240 | Influenza Virus Infectious NYMC X-327 44280 E17 | £0.00 |
18/242 | Influenza Virus Infectious A/Kansas/14/2017 43880 E8 | £0.00 |
18/244 | Human Chorionic Gonadotropin (hCG) (6th International Standard) | £147.00 |
18/248 | Von Willebrand Factor Concentrate (WHO 3rd International Standard) | £147.00 |
18/B731 | Anti CMV QC1 QCRCMVQC1 | £117.00 |
18/B732 | QCRNEGQC1-Negative Quality Control Serum: Sample1 | £31.00 |
18/B733 | QCREBVIgMQC1 | £106.00 |
18/B742 | QCRLYMEIgMQC1 IgM Anti-Lyme QC1 | £99.00 |
19/102 | Influenza anti-A/Brisbane/02/2018-like (H1N1) HA Serum (Sheep 698, 699, 700, 701) | £120.00 |
19/104 | Influenza antigen A/Kansas/14/2017 (NYMC X-327) (H3N2) | £120.00 |
19/106 | Influenza Virus Infectious IVR-195 44300 E9 | £0.00 |
19/108 | Trastuzumab (1st WHO international Standard) | £141.00 |
19/112 | Influenza Virus Infectious NIB-110 | £0.00 |
19/114 | Anti-Human Neutrophil Antibody 3a WHO Reference Reagent | £147.00 |
19/116 | 1st WHO Plasmodium Vivax Antigen (LDH) | £147.00 |
19/118 | Ferritin (Human, Recombinant) | £147.00 |
19/120 | Influenza Virus Infectious X-327 A 44310 E18 | £0.00 |
19/146 | Influenza Virus Infectious CNIC-1903 | £0.00 |
19/148 | Influenza Virus Infectious CNIC-1902 44320 E10 | £0.00 |
19/152 | Influenza anti-A/Kansas/14/2017 - Like (H3N2) HA Serum | £120.00 |
19/154 | Influenza Antigen A/Kansas/ 12/2017 (IVR-195) (H3N2) | £120.00 |
19/156 | Panel of recombinant antibody controls for Cytokine Release Assays | £585.00 |
19/160 | Influenza Virus Infectious A/California/7/09 44430 E6 | £0.00 |
19/164 | VZV Nucleic acid amplification techniques (1st WHO International Standard) | £147.00 |
19/166 | Insulin-like Growth Factor I, for Immunoassay (2nd WHO international Standard) | £147.00 |
19/172 | Influenza Virus Infectious BVR-11 | £0.00 |
19/174 | Influenza Virus Infectious IVR-197 (H3N2) 44850 E14 | £0.00 |
19/176 | Influenza Virus Infectious B/Victoria/705/2018 | £0.00 |
19/178 | 1st WHO International Standard for Anti-MERS-CoV Immunoglobulin G (Human) | £147.00 |
19/180 | Non WHO Reference material Working reagent for Anti-MERS-CoV Antibody | £132.00 |
19/188 | 3rd International Standard Thrombin | £147.00 |
19/192 | Influenza Virus Infectious IVR-202 (H3N2) 44880 E10 | £0.00 |
19/194 | Influenza Virus Infectious B/Brisbane/35/2018 | £0.00 |
19/198 | 1st WHO Reference Reagent for anti-malaria (Plasmodium Vivax) human plasma | £103.00 |
19/204 | Influenza Antigen A/Newcastle/82/2018 (H3N2) (cell derived) | £120.00 |
19/206 | Influenza Virus Infectious X-181 45030 E8 | £0.00 |
19/208 | Influenza Antigen B/Victoria/705/2018 (BVR-11) (B Victoria Lineage) | £120.00 |
19/210 | Influenza Antigen B/Darwin/7/2019 (B Victoria Lineage) (Cell Derived) | £120.00 |
19/212 | Influenza Antigen A/South Australia/34/2019 (IVR-197) (H3N2) | £120.00 |
19/216 | Influenza Anti-A/South Australia/34/2019-Like (H3N2) HA Serum (Sheep 712, 713, 714, 715, 716) | £120.00 |
19/224 | Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV16, HPV18, HPV6, HPV11 | £401.00 |
19/226 | Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV31, HPV33, HPV45, HPV52, HPV58 | £536.00 |
19/228 | Influenza Virus Infectious A/South Australia/34/2019 | £0.00 |
19/230 | Influenza Virus Infectious A/Christchurch/516/2019 H3N2 45010 E4 | £0.00 |
19/238 | Influenza Antigen B/Washington/02/2019 (B Victoria Lineage) | £120.00 |
19/240 | British Working Standard for Anti-HCV | £35.00 |
19/244 | Third WHO International Standard for Anti-Rabies Immunoglobulin | £147.00 |
19/246 | 1st International Standard for human vascular endothelial growth factor-165 (VEGF165) | £132.00 |
19/256 | Influenza Virus Infectious BX-85C 45230 E13 | £0.00 |
19/258 | Influenza Virus Infectious CNIC-1906 44910 E3+3/E9/E1 | £0.00 |
19/260 | Anti-thyroid peroxidase antibodies (1st WHO International Standard) | £147.00 |
19/276 | Influenza Virus Infectious NIB-121 (H3N2) 45180 E7/E1/E5 | £0.00 |
19/290 | First WHO International Standard for anti-human papillomavirus type 33 serum | £147.00 |
19/296 | First WHO International Standard for anti-human papillomavirus type 52 serum | £147.00 |
19/298 | First WHO International Standard for anti-human papillomavirus type 6 serum | £147.00 |
19/300 | First WHO International Standard for anti-human papillomavirus type 58 serum | £147.00 |
19/306 | Influenza Antigen A/Victoria/2454/2019 (IVR-207) (H1N1) | £120.00 |
19/308 | Influenza Antigen B/Singapore/INFTT-16-0610/2016 (B Yamagata lineage) (cell derived) | £120.00 |
19/312 | Influenza Antigen A/Guangdong-Maonan/SWL1536/2019 (CNIC-1909) (H1N1) | £120.00 |
19/314 | Influenza Anti-A/ Guangdong-Maonan/SWL 1536/2019-like (H1N1) HA Serum (Sheep 723, 724, 725, 726, 727, 728) | £120.00 |
19/316 | Influenza anti-A/hongKong/2671/2019-like (H3N2) HA Serum (Sheep 729, 730, 731, 732, 733, 734) | £120.00 |
19/318 | Influenza anti-B/Washington/02/2019-like (B Victoria lineage) HA Serum (Sheep 737, 738, 739, 740, 741, 742) | £120.00 |
19/320 | Influenza anti-N2 Neuraminidase Serum (A/South Australia/34/2019) (Sheep 735, 736) | £120.00 |
19/322 | Influenza anti-B/Phuket/3073/2013-like (B Yamagata Lineage) HA serum (Sheep 743, 744, 745, 746, 747, 748) | £120.00 |
19/B747 | QCRHIV2QC4 - Anti HIV2 Quality Control Serum Sample 4 | £99.00 |
19/B754 | Anti-Rubella QC2 | £154.00 |
20/102 | Influenza Virus Infectious IVR-207 (H1N1) 45370 E4/E6/E1 | £0.00 |
20/106 | Influenza Virus Infectious A/Victoria/2454/2019 (H1N1) 45360 E4/E1 | £0.00 |
20/108 | Influenza Antigen A/HongKong/2671/2019 (NIB-121)(H3N2) | £120.00 |
20/110 | SARS-CoV-2 (NAT) | £35.00 |
20/112 | IVIG + Anti-D (13/148)x2 Negative Control IVIG (12/300) x2 | £315.00 |
20/132 | Influenza Antigen A/HongKong/2671/2019 (IVR-208) (H3N2) | £120.00 |
20/134 | Influenza Virus Infectious BX-57 45430 E4/E10/E1 | £0.00 |
20/138 | Working Reagent for SARS-CoV-2 RNA | £132.00 |
20/146 | First WHO International Standard for SARS-CoV-2 RNA | £147.00 |
20/152 | First WHO International Standard for Mycobacterium tuberculosis (H37Rv) DNA for NAT-based assays | £147.00 |
20/162 | NIBSC Anti-SARS-CoV-2 Antibody Diagnostic Calibrant | £101.00 |
20/164 | Influenza Virus Infectious BX-87C (B/VIC) 45460 E3/E10/E1 | £0.00 |
20/170 | NHS winter Multiplex Working Reagent for Nucleic acid amplification testing (NAT) | £62.00 |
20/172 | 1st International Standard for anti-EV68 Serum | £147.00 |
20/174 | First WHO International Standard for anti-human papillomavirus type 11 serum | £147.00 |
20/176 | First WHO International Standard for anti-human papillomavirus type 31 serum | £147.00 |
20/178 | First WHO International Standard for anti-human papillomavirus type 45 serum | £147.00 |
20/180 | Influenza A (H1N1) Panel | £59.00 |
20/182 | Influenza A (H3N2) Panel | £59.00 |
20/184 | Influenza B Panel | £59.00 |
20/186 | RSV A Panel | £59.00 |
20/188 | RSV B Panel | £59.00 |
20/190 | SARS-CoV-2 Panel | £59.00 |
20/202 | Anti-Lassa Virus Antibodies (1st International Standard) | £147.00 |
20/214 | Influenza Virus Infectious IVR-216 (H1N1) 45630 E4/D6/E1 | £0.00 |
20/218 | Follicle Stimulating Hormone (3rd International Standard) | £147.00 |
20/220 | Influenza Virus Infectious IVR-217 (H1N1) 45640 E4/D6/E1 | £0.00 |
20/234 | Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum (Sheep 749, 750, 751, 752, 753, 754) | £120.00 |
20/236 | Influenza Virus Infectious X-349 (H1N1) E3/E9/E1 45720 | £0.00 |
20/238 | Influenza Virus Infectious X-349A (H1N1) E3/E11/E1 45730 | £0.00 |
20/250 | WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Type 1 | £147.00 |
20/252 | WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Type 2 | £147.00 |
20/254 | WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Type 3 | £147.00 |
20/256 | WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Types 1, 2 and 3 | £147.00 |
20/264 | Influenza Virus Infectious X-341 + 1P (H3N2) | £0.00 |
20/292 | 2nd International Standard for Factor XIII Plasma, Human | £147.00 |
20/294 | Influenza Virus Infectious X-347 (H3N2) | £0.00 |
20/296 | Influenza Virus Infectious X-347A (H3N2) | £0.00 |
20/302 | WHO International Reference Reagent for GUT Microbiome analysis by NGS (Gut-Mix RR) | £147.00 |
20/304 | WHO Reference Reagent for GUT Microbiome analysis by NGS (DNA-Gut-HiLo) | £147.00 |
20/310 | Influenza Virus Infectious A/Cambodia/E0826360/2020 (H3N2) | £0.00 |
20/318 | Influenza Virus Infectious IVR-221 (H3N2) | £0.00 |
20/322 | Influenza Virus Infectious A/Singapore/INFIMH-16-0019/2016 (H3N2) | £0.00 |
20/B758 | QCRHIV1p24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2 | £117.00 |
20/B760 | QCRHBsQC1 | £154.00 |
20/B762 | QCRHIV1QC2 - Anti-HIV Quality Control Serum sample 2 | £99.00 |
20/B764 | QCRSARSCoV2QC1 | £59.00 |
20/B767 | QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1 | £154.00 |
20/B774 | QCRPARVB19IgMQC1 - IgM Anti-Parvovirus B19 Quality Control Reagent 1 | £102.00 |
21/100 | Influenza Antigen A/Cambodia/e0826360/2020 (IVR-224) (H3N2) | £120.00 |
21/110 | Working Reagent for Lassa virus RNA | £132.00 |
21/112 | ‘First WHO International Standard for Lassa virus RNA’ | £147.00 |
21/116 | Influenza Antigen A/Tasmania/503/2020 (IVR-221) (H3N2) | £120.00 |
21/118 | Influenza anti-A/Cambodia/e0826360/ 2020-Like (H3N2) HA Serum | £120.00 |
21/120 | Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum | £120.00 |
21/122 | Influenza Virus Infectious X-357A (H3N2) | £0.00 |
21/124 | Influenza Virus Infectious B/HongKong/574/2019 (B-Victoria lineage) | £0.00 |
21/130 | Influenza Virus Infectious SAN-004A (H3N2) | £0.01 |
21/132 | Influenza Virus Infectious B/Phuket/3073/2013 (B-Yamagata lineage) | £0.00 |
21/136 | Influenza Antigen B/Phuket/3073/2013 (B Yamagata lineage) | £120.00 |
21/148 | Influenza Virus Infectious X-359 (H3N2) | £0.00 |
21/150 | Influenza Virus Infectious X-359A (H3N2) | £0.00 |
21/156 | Influenza Virus Infectious BX-93A (B-Victoria Lineage) | £0.00 |
21/158 | Influenza Virus Infectious BX-93B (B-Victoria Lineage) | £0.00 |
21/160 | Influenza Virus Infectious X-353 (H3N2) | £0.00 |
21/164 | Influenza Virus Infectious X-355B (H3N2) | £0.00 |
21/166 | Influenza Virus Infectious X-355A-CL (H3N2) | £0.00 |
21/170 | 1st International Standard 2022 for the in vitro bioactivities of Cetuximab | £147.00 |
21/180 | Meningococcal Capsular Group W polysaccharide | £132.00 |
21/186 | Influenza Virus Infectious A/Tasmania/503/2020 (H3N2) | £0.00 |
21/190 | Influenza Virus Infectious X-361A (H3N2) | £0.00 |
21/192 | Influenza Virus Infectious BX-97A (B-Victoria Lineage) | £0.00 |
21/194 | Influenza Virus Infectious A/Hong Kong/2671/2019 | £0.00 |
21/196 | Influenza Virus Infectious IVR-224 (H3N2) | £0.00 |
21/204 | Influenza Virus Infectious IVR-227 (H3N2) | £0.00 |
21/212 | Influenza Virus Infectious A/Darwin/6/2021 (H3N2) | £0.00 |
21/214 | Influenza Virus Infectious A/Darwin/9/2021 (H3N2) | £0.00 |
21/216 | Influenza Virus Infectious BVR-25 (B-Victoria Lineage) | £0.00 |
21/224 | Influenza Virus Infectious B/Austria/1359417/2021 (B/Victoria Lineage) | £0.00 |
21/226 | Influenza Virus Infectious NIB-127 (H3N2) | £0.00 |
21/228 | Influenza Virus Infectious NIB-126 (H3N2) | £0.00 |
21/230 | 1st WHO Reference Reagent Tetanus Antitoxin Equine for use in Flocculation Test | £147.00 |
21/238 | Influenza Virus Infectious A/Guangdong-Maonan/SWL/1536/2019 (H1N1) | £0.00 |
21/240 | Influenza Virus Infectious CNIC-1909 (H1N1) | £0.00 |
21/242 | Influenza Virus Infectious B/Singapore/WUH4618/2021 (B-Victoria Lineage) | £0.00 |
21/244 | Influenza Virus Infectious B/Michigan/1/2021 (B/Victoria Lineage) | £0.00 |
21/246 | Influenza Virus Infectious IVR-228 (H3N2) | £0.00 |
21/248 | Influenza Virus Infectious BVR-27 (B-Victoria Lineage) 46580 | £0.00 |
21/252 | Influenza Virus Infectious IVR-215 (H1N1) | £0.00 |
21/266 | 1st International Standard 2022 Anti-β2GPI IgG 200 IU/Vial | £147.00 |
21/268 | Anti-pneumococcal serotype 1 monoclonal antibody (clone13-110A | £85.00 |
21/270 | Anti-pneumococcal serotype 3 monoclonal antibody (clone 15-103FC11 IH5) | £85.00 |
21/272 | Anti-pneumococcal serotype 5 monoclonal antibody (clone 1366LC1 IE11) | £85.00 |
21/274 | Anti-pneumococcal serotype 6A / 6C monoclonal antibody (clone 14-107 JG10 IA1/IB1 IIG10) | £85.00 |
21/276 | Anti-pneumococcal serotype 7F monoclonal antibody (clone 15-102HG6 ID8) | £85.00 |
21/278 | Anti-pneumococcal serotype 8 monoclonal antibody (clone 7D3) | £85.00 |
21/280 | Anti-pneumococcal serotype 9N monoclonal antibody (clone 18-125BG4 ID4) | £85.00 |
21/282 | Anti-pneumococcal serotype 9V monoclonal antibody (clone 15-112EG9 IE2) | £85.00 |
21/284 | Anti-pneumococcal serotype 10A monoclonal antibody (clone 17-117IA3 IIB6) | £85.00 |
21/286 | Anti-pneumococcal serotype 12F monoclonal antibody (clone 1C1) | £85.00 |
21/288 | Anti-pneumococcal serotype 14 monoclonal antibody (clone 13-111A) | £85.00 |
21/290 | Anti-pneumococcal serotype 18C monoclonal antibody (clone 15-104AG5 IIH4) | £85.00 |
21/292 | Anti-pneumococcal serotype 19A monoclonal antibody (clone 14-105IH8 IE12) | £85.00 |
21/294 | Anti-pneumococcal serotype 22F monoclonal antibody (clone 17-122 CG1 IC3) | £85.00 |
21/298 | Influenza Virus Infectious A/Michigan/173/2020 (H3N2) | £0.00 |
21/306 | Influenza Virus Infectious SAN-010 (H3N2) | £0.00 |
21/308 | 2nd International Standard for Interleukin-6 | £147.00 |
21/314 | Influenza Antigen A/Darwin/6/2021 (IVR-227) (H3N2) | £120.00 |
21/316 | Influenza Antigen B/Austria/1359417/2021 (BVR-26) (B Victoria Lineage) | £120.00 |
21/318 | Influenza Antigen A/Darwin/9/2021 (IVR-228) (H3N2) | £120.00 |
21/320 | Influenza Antigen A/Darwin/9/2021 (SAN-010) (H3N2) | £120.00 |
21/322 | Influenza Anti-B Neuraminidase Serum (B/Phuket/3073/2013) | £120.00 |
21/324 | Influenza Anti-A/Darwin/9/2021-Like (H3N2) HA Serum | £120.00 |
21/326 | Influenza Anti-B/Austria/1359417/2021 Like (B Victoria Lineage) HA Serum | £120.00 |
21/330 | Influenza Antigen B/Michigan/01/2021 | £120.00 |
21/332 | 1st International Reference Panel for anti-Lassa fever virus antibodies | £299.00 |
21/336 | Influenza Virus Infectious B/Washington/02/2019 (B-Victoria lineage) | £0.00 |
21/338 | 1st International Standard 2022 Antibodies to SARS-CoV-2 variants of concern | £147.00 |
21/340 | Second WHO International Standard for anti-SARS-CoV-2 immunoglobulin. | £147.00 |
21/346 | Influenza Virus Infectious A/Victoria/2570/2019 (H1N1) | £0.00 |
21/348 | Influenza Virus Infectious B/Utah/9/2014 (B-Yamagata lineage) | £0.00 |
21/350 | Influenza Virus Infectious BX-59A (B-Yamagata lineage) | £0.00 |
21/352 | Influenza Virus Infectious B/Brisbane/9/2014 (B-Yamagata) | £0.00 |
21/366 | Influenza Virus Infectious SAN-011 (H1N1) | £0.00 |
21/368 | SARS-Cov-2 Antigen 1st WHO International Standard | £147.00 |
21/380 | Influenza Virus Infectious IVR-208 (H3N2) | £0.00 |
21/382 | Influenza Virus Infectious X-367A (H3N2) | £0.00 |
21/384 | Influenza Virus Infectious X-369A (H3N2) | £0.00 |
21/388 | Influenza Virus Infectious B/Guangdong-Zhenjiang/1516/2021 (B-Victoria Lineage) | £0.00 |
21/B777 | Ferritin Quality Control Sample | £168.00 |
21/B882 | QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1 | £99.00 |
21/B889 | QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1 | £99.00 |
22/100 | Influenza Antigen A/Victoria/2570/2019 (IVR-215) (H1N1) | £120.00 |
22/108 | Reference Panel for Lassa virus RNA | £314.00 |
22/118 | Influenza Virus Infectious NIB-129 (H3N2) | £0.00 |
22/134 | Influenza Virus Infectious BX-107A (B-Victoria Lineage) | £0.00 |
22/136 | Influenza Virus Infectious A/North Carolina/01/2021 (H1N1) X-375 | £0.00 |
22/138 | Influenza Virus Infectious A/Indiana/02/2020 (H1N1) | £0.00 |
22/140 | Influenza Virus Infectious A/Netherlands 00007/2021 (H3N2) SAN-012 | £0.00 |
22/142 | Influenza Virus Infectious A/Sydney/5/2021 (H1N1) SAN-013 | £0.00 |
22/144 | Influenza Virus Infectious A/Darwin/22/2021 (H3N2) SAN-014 | £0.00 |
22/146 | Influenza Virus Infectious A/Brisbane/02/2018 (H1N1) | £0.00 |
22/148 | Meningococcal Capsular Group Y Polysaccharide | £132.00 |
22/154 | Influenza Virus Infectious B/Connecticut/01/2021 (B-Victoria Lineage) | £0.00 |
22/156 | Influenza Virus Infectious A/Norway/16606/2021 (H3N2) NYMC X-373A | £0.00 |
22/158 | Influenza Virus Infectious A/Netherlands/00007/2021 (H3N2) NYMC X-377 | £0.00 |
22/172 | Influenza Virus Infectious A/Lyon/820/2021 (H1N1) NIB-132 | £0.00 |
22/174 | Influenza Virus Infectious A/Victoria/2570/2019 (H1N1) NYMC X-379 | £0.00 |
22/178 | Influenza Virus Infectious A/Darwin/22/2021 (H3N2) NIB -130 | £0.00 |
22/180 | Influenza Virus Infectious A/Guizhou/Liuzhite/326/2022 (H3N2) CNIC-2206 | £0.00 |
22/200 | Influenza Virus Infectious A/Sydney/5/2021 (H1N1) | £0.00 |
22/204 | Influenza Virus Infectious B/Austria/1359417/2021 (B-Victoria lineage) BVR-26 | £0.00 |
22/212 | NIBSC Reference Reagent for DNA extractions of gut microbiome samples (WC-Gut-RR) | £132.00 |
22/214 | Influenza Virus Infectious CBER-48A (A/Sydney/5/2021) (H1N1) | £0.00 |
22/218 | Working Reagent for anti-monkeypox virus antibodies | £55.00 |
22/220 | Influenza Antigen A/Sydney/5/2021 (SAN-013) (H1N1) | £120.00 |
22/222 | Influenza Antigen A/Sydney/175/2022 (IVR-235) (H1N1) | £120.00 |
22/224 | Influenza anti-A/Sydney/5/2021-like (H1N1) HA serum | £120.00 |
22/226 | Influenza Anti-A/Darwin/9/2021-like (H3N2) HA Serum | £120.00 |
22/234 | Influenza Virus Infectious IVR-235 (A/Sydney/175/2022 (H1N1) | £0.00 |
22/236 | Anti-pneumococcal serotype 2 monoclonal antibody (clone 2D1) | £85.00 |
22/238 | Anti-pneumococcal serotype 4 monoclonal antibody (clone 14-100JA2 IIE7 2H7) | £85.00 |
22/240 | Anti-pneumococcal serotype 6B monoclonal antibody (clone 14-102GA3 ID10 1B10) | £85.00 |
22/242 | Anti-pneumococcal serotype 11A monoclonal antibody (clone 8G12) | £85.00 |
22/244 | Anti-pneumococcal serotype 15B monoclonal antibody (clone 3D3) | £85.00 |
22/246 | Anti-pneumococcal serotype 17F monoclonal antibody (clone 17-120DG2 IF2) | £85.00 |
22/248 | Anti-pneumococcal serotype 20 monoclonal antibody (clone 18-121 DF9 IIG8 1B6) | £85.00 |
22/250 | Anti-pneumococcal serotype 33F monoclonal antibody (clone 3B2) | £85.00 |
22/254 | Anti-pneumococcal serotype 6C monoclonal antibody (clone 1B2) | £85.00 |
22/256 | Anti-pneumococcal serotype 15A/B monoclonal antibody (clone 3A4) | £85.00 |
22/258 | Anti-pneumococcal serotype 16F monoclonal antibody (clone 20-121HC4 IA4 IE6) | £85.00 |
22/260 | Anti-pneumococcal serotype 19F monoclonal antibody (clone 8E9- 1B12) | £85.00 |
22/262 | Anti-pneumococcal serotype 23F monoclonal antibody (clone 15-113HA6 IG2) | £85.00 |
22/264 | Anti-pneumococcal serotype 24F monoclonal antibody (clone 1A6) | £85.00 |
22/266 | Anti-pneumococcal serotype 35B monoclonal antibody (clone 3F6) | £85.00 |
22/268 | Influenza Virus Infectious SAN-015 (A/Lyon/820/2021) (H1N1) | £0.00 |
22/270 | 1st International Reference Panel for antibodies to SARS-CoV-2 variants of concern | £299.00 |
22/272 | 1st International Reference Panel for Infliximab anti-drug antibodies | £299.00 |
22/276 | Anti-pneumococcal serotype 2 monoclonal antibody (clone 1G7) | £85.00 |
22/278 | Anti-pneumococcal serotype 15B monoclonal antibody (clone 2F4) | £85.00 |
22/280 | Anti-pneumococcal serotype 23F monoclonal antibody (clone 15-113HA5 IE2 IE2) | £85.00 |
22/282 | Anti-pneumococcal serotype 24F monoclonal antibody (clone 2F2) | £85.00 |
22/284 | Anti-pneumococcal serotype CPS monoclonal antibody (clone 14-108BA5 IE10) | £85.00 |
22/286 | Anti-pneumococcal serotype 4 monoclonal antibody (clone 14-100JA2 IIE7 2G6) | £85.00 |
22/288 | Anti-pneumococcal serotype 5 monoclonal antibody (clone 1366KG3 IA11) | £85.00 |
22/290 | Anti-pneumococcal serotype 6B monoclonal antibody (clone 14-102CC2 ID9) | £85.00 |
22/292 | Anti-pneumococcal serotype 8 monoclonal antibody (clone 6G1) | £85.00 |
22/294 | Anti-pneumococcal serotype 10A monoclonal antibody (clone 17-117DE8 IIE9) | £85.00 |
22/296 | Anti-pneumococcal serotype 11A monoclonal antibody (clone 2E2) | £85.00 |
22/298 | Anti-pneumococcal serotype 12F monoclonal antibody (clone 1C8) | £85.00 |
22/300 | Anti-pneumococcal serotype 15A-B monoclonal antibody (clone 1B4) | £85.00 |
22/302 | Anti-pneumococcal serotype 16F monoclonal antibody (clone 20-121EC11 IIF10 VE2) | £85.00 |
22/304 | Anti-pneumococcal serotype 17F monoclonal antibody (clone 17-120AE4 IE3 IG2) | £85.00 |
22/306 | Anti-pneumococcal serotype 22F monoclonal antibody (clone 17-122 JB11 IB11) | £85.00 |
22/308 | Anti-pneumococcal serotype 35B monoclonal antibody (clone 3F9) | £85.00 |
22/312 | Influenza Virus Infectious A/Norway/31694/2022 (H1N1) | £0.00 |
22/316 | Influenza Virus Infectious A/Victoria/4897/2022 (H1N1) | £0.00 |
22/318 | Influenza Virus Infectious IVR-238 (A/Victoria/4897/2022 (H1N1) | £0.00 |
22/320 | Influenza Antigen A/Victoria/4897/2022 (IVR-238) (H1N1) | £120.00 |
22/B891 | QCRTOXOIgMQC1 IgM Anti-Toxoplasma QC1 | £117.00 |
22/B893 | QCRHBsGQC2-Anti HBsAg Quality Control Serum: Sample2 | £99.00 |
22/B895 | QCRHIV2QC2-Anti HIV2: Quality Control Serum: Sample2 | £168.00 |
22/B896 | Anti-SARS-CoV-2 Verification Panel for Serology Assays | £434.00 |
23/100 | Influenza anti-A/Victoria/4897/2022-like (H1N1) HA Serum | £120.00 |
23/112 | |